mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.07 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.07 |
mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.07 |
mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.07 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.08 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.08 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
0.08 |
mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.08 |
mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.08 |
mRNA |
BRD-K71781559 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.08 |